Cargando…
The Personalisation of Glioblastoma Treatment Using Whole Exome Sequencing: A Pilot Study
The molecular heterogeneity of glioblastoma has been linked to differences in survival and treatment response, while the development of personalised treatments may be a novel way of combatting this disease. Here we show for the first time that low passage number cells derived from primary tumours ar...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074406/ https://www.ncbi.nlm.nih.gov/pubmed/32041307 http://dx.doi.org/10.3390/genes11020173 |